SCHEMBL7363755

SCHEMBL7363755

N#Cc1cccc(CC(N)c2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.54
KCNH2 Q12809 2/20 0.54
GLA P06280 1/20 0.40
FOLH1 Q04609 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
VCAM1 P19320 1/20 0.40
DPP4 P27487 2/20 0.39
DPP7 Q9UHL4 2/20 0.39
FAP Q12884 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
MMP2 P08253 1/20 0.38
FBP1 P09467 1/20 0.38
P4HB P07237 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
EPHX1 P07099 1/20 0.37
CYP19A1 P11511 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7363757 0.87 KCNJ1 (0.51) KCNJ1KCNH2LOXL2VCAM1DPP4
SCHEMBL7364288 0.85 KCNJ1 (0.56) KCNJ1KCNH2GLAFOLH1LOXL2
SCHEMBL7359657 0.83 SLC6A2 (0.46) GLAFOLH1LOXL2DPP4DPP7
SCHEMBL7364388 0.81 SLC6A2 (0.56) GLAFOLH1DPP4DPP7FAP
SCHEMBL4749835 0.80 FOLH1 (0.44) GLAFOLH1DPP4DPP7FAP
SCHEMBL7364292 0.76 KCNH2 (0.53) KCNJ1KCNH2LOXL2VCAM1P4HB
SCHEMBL6158758 0.72 FOLH1 (0.48) KCNJ1KCNH2GLAFOLH1DPP4
SCHEMBL17266185 0.72 SLC6A2 (0.49) SLC6A2SLC6A4EPHX1
SCHEMBL6331351 0.72 SLC6A2 (0.49) SLC6A2SLC6A4EPHX1
SCHEMBL7453828 0.72 KCNJ1 (0.60) KCNJ1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0892780-A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1999-01-27 EP disclosed
WO-1997030971-A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-28 WO disclosed